LBF20203PG02: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1716 | |LipidBank=XPR1716 | ||
|LipidMaps=LMFA03010149 | |LipidMaps=LMFA03010149 | ||
|SysName=6- | |SysName=6-Oxo-9alpha,11alpha,15S-trihydroxy-prosta-13E,17Z-dien-1-oic acid | ||
|Common Name=&& | |Common Name=&&delta^{17}-6-keto Prostaglandin F_1alpha | ||
|Source= Delta ^{17}-6-keto PGF1 alpha is no enzymatic hydrolysis product of PGI3. | |Source= Delta ^{17}-6-keto PGF1 alpha is no enzymatic hydrolysis product of PGI3. | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Revision as of 04:36, 21 April 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1716 |
| LipidMaps | LMFA03010149 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20203PG02 |
| δ17-6-keto Prostaglandin F_1α | |
|---|---|
| |
| Structural Information | |
| 6-Oxo-9α,11α,15S-trihydroxy-prosta-13E,17Z-dien-1-oic acid | |
| |
| Formula | C20H32O6 |
| Exact Mass | 368.219888756 |
| Average Mass | 368.46448 |
| SMILES | C(=CC[C@@H](O)C=C[C@H]([C@@H](CC(=O)CCCCC(O)=O)1)[C@@H](C[C@@H]1O)O)CC |
| Physicochemical Information | |
| Delta ^{17}-6-keto PGF1 alpha is no enzymatic hydrolysis product of PGI3. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
